http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0806713-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a08943cf95b7bf75fff3c69d5c3df82b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b455945e2cd33409b9ff0dd51b7df2d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-335
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08
filingDate 2008-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9797789458cea1a2b0d6ff201a910967
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b3ce372ce6ae7fd2acd31e2c1a7f689
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04817477d5f5cb5ea19db9d1c3db785f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5fbace7fa4eea920a3fa9d2d7650bcb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_883093b7aefa98b5e7ae3f801153a2c2
publicationDate 2017-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0806713-A8
titleOfInvention STABLE THIACUMICIN COMPOSITIONS
abstract STABLE THIACUMICIN COMPOSITIONS. The present invention relates to pharmaceutical compositions of one or more tiacumycins that exhibit improved stability and methods of treatment using such formulations. The formulations contain one or more tiacumycins, such as diphymycin, and one or more antioxidants, such as butylated hydroxytoluene, and, optionally, one or more pharmaceutically acceptable excipients.
priorityDate 2007-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527601

Total number of triples: 30.